Table 3 Summary results of the meta-analysis of mean values of each Biomarker in non-survivor and survivor cases
Anomalies | SMD (95% CI) | P-value | Heterogeneity I2 (%) | Number of studies | Sample size for Non-survivor | Sample size survivor |
|---|---|---|---|---|---|---|
Inflammation | ||||||
 IL-6 | 1.23(0.77;1.68) | < 0.001 | 61 | 2 | 98 | 177 |
Blood routine | ||||||
 Lymphocytes count | −0.67(−1.18; −0.17) | 0.009 | 75 | 3 | 130 | 197 |
 White Blood Cells | 0.89(0.04; 1.75) | 0.04 | 90 | 2 | 98 | 177 |
Biochemestry | ||||||
 Creatinemia | −0.09(−0.46;0.27) | 0.62 | 12 | 2 | 76 | 60 |
 Total bilirubin | 0.55(0.20;0.89) | 0.002 | 0 | 2 | 76 | 60 |
 LDH | 1.48(0.57;2.40) | 0.002 | 90 | 2 | 98 | 170 |
 Ferritin | 0.76(−0.33;1.90) | 0.18 | 93 | 2 | 90 | 122 |
Blood clothing | ||||||
 PT | 0.30(−0.14;0.75) | 0.18 | 68 | 3 | 130 | 188 |